Figures computed from official regulatory filings — methodology.
| Insider | Type | Value · USD | |
|---|---|---|---|
| Cao Yanling | Other | $441.1M | SEC |
| AstraZeneca UK LTD | Other | $776.5M | SEC |
| Boyu Capital Fund III, L.P. | Other | $15.9M | SEC |
| Hu Edward | OtherD | — | SEC |
| Jacques Rachelle Suzanne | OtherD | — | SEC |
| Ragatz William | OtherD | — | SEC |
| Drappa Jorn | OtherD | — | SEC |
| Ragatz William | Other | $861.3K | SEC |
| Kastenmayer James Paul | OtherD | — | SEC |
| Ragatz William | OtherD | — | SEC |
| Wicki Andreas | Other | $92.8M | SEC |
| Chan Mitchell | OtherD | — | SEC |
| Hu Edward | Other | $11M | SEC |
| Ragatz William | OtherD | — | SEC |
| Drappa Jorn | OtherD | — | SEC |
| Yao Zhengbin | OtherD | — | SEC |
| Chan Mitchell | OtherD | — | SEC |
| Hu Edward | OtherD | — | SEC |
| Yao Zhengbin | OtherD | — | SEC |
| Nolet Chris | OtherD | — | SEC |
| Nolet Chris | OtherD | — | SEC |
| Yao Zhengbin | Other | $10.6M | SEC |
| Yao Zhengbin | OtherD | — | SEC |
| Boyu Capital Fund III, L.P. | Other | $441.1M | SEC |
| Drappa Jorn | OtherD | — | SEC |